InvestorsHub Logo
Followers 44
Posts 10493
Boards Moderated 0
Alias Born 01/13/2016

Re: None

Tuesday, 11/29/2022 5:24:27 AM

Tuesday, November 29, 2022 5:24:27 AM

Post# of 474389
Questions that could have been asked..
Dr m with a 94% ole continuance, have you noticed additional health benefits to this population? Like eyesight , lack of major illness. Strong immune responses to covid? Better sleep? Less agitation?
Are additional observatory indications being made?

With the OLE in PDD about to be released have you noticed any additional benefits that you will be monitoring in the AD OLE trial?

When you announced that TLD would be released in a peer reviewed article after CTAD, is it your expectation that another confirmatory Phase 3 AD trial will be necessary? Sorry is that too forward?

You say the commonality of effect is found in the higher dosage, so approximately 170 of the current AD trial we’re in the 50mg..
Are all 480 or so OLE patients being given the higher dosage?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News